Objective
Ectins will find commercially viable ways to derive conditionally immortalised neural stem cells, identify their key phenotype features, patterns of gene expression and biological activities that predict in vivo efficacy. We shall demonstrate clinical potential, study dosing and cell placement through developing predictive animal models of human neurological disease states. Media formulations will be optimised for long term viability, maintain efficacious properties and minimise toxicity. We shall develop non-invasive magnetic resonance imaging methods to follow the activity of grafted cells in human stroke patients. Scientific innovation at all stages of the programme will ensure future product pipelines.
Fields of science
Call for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
SE1 0NZ London
United Kingdom
See on map
Participants (8)
20132 Milano
See on map
75654 Paris
See on map
SE5 8AF London
See on map
W1W 7BS London
See on map
82152 Planegg-martinsried
See on map
4040 Jyllinge
See on map
CB2 1TN Cambridge
See on map
00014 Helsinki
See on map